Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer (Q33808012)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer |
scientific article |
Statements
1 reference
Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer (English)
1 reference
Rakesh K Jain
1 reference
Paul Shellito
1 reference
Emmanuelle di Tomaso
1 reference
Rekha Samuel
1 reference
Marek Ancukiewicz
1 reference
Christopher G Willett
1 reference
Brian G Czito
1 reference
Lei Xu
1 reference
Dan G Duda
1 reference
Daniel C Chung
1 reference
Gregory Y Lauwers
1 reference
Pei-Chun Lin
1 reference
Martin Poleski
1 reference
Rex Bentley
1 reference
Jeffrey W Clark
1 reference
13 October 2009
1 reference
1 reference
69
1 reference
20
1 reference
7905-7910
1 reference
Identifiers
1 reference
1 reference
1 reference